Healthcare provider profile · identity verified

Gilbert Alligood, M.D.

Internal Medicine · MIDDLESEX, NC · NPI 1588644157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	125
Amlodipine Besylate	Amlodipine Besylate	493	117
Losartan Potassium	Losartan Potassium	373	94
Metoprolol Succinate	Metoprolol Succinate	357	83
Omeprazole	Omeprazole	344	74
Levothyroxine Sodium	Levothyroxine Sodium	320	76
Lisinopril	Lisinopril	282	74
Gabapentin	Gabapentin	266	58
Tamsulosin Hcl	Tamsulosin Hcl	263	54
Metformin Hcl	Metformin Hcl	223	50
Furosemide	Furosemide	221	58
Trazodone Hcl	Trazodone Hcl	204	48
Hydrochlorothiazide	Hydrochlorothiazide	196	44
Pravastatin Sodium	Pravastatin Sodium	190	47
Pantoprazole Sodium	Pantoprazole Sodium	175	43
Albuterol Sulfate Hfa	Albuterol Sulfate	167	36
Rosuvastatin Calcium	Rosuvastatin Calcium	162	42
Metoprolol Tartrate	Metoprolol Tartrate	160	33
Zolpidem Tartrate	Zolpidem Tartrate	152	23
Potassium Chloride	Potassium Chloride	147	33
Eliquis	Apixaban	143	29
Sertraline Hcl	Sertraline Hcl	142	29
Simvastatin	Simvastatin	127	36
Jardiance	Empagliflozin	124	26
Citalopram Hbr	Citalopram Hydrobromide	122	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	31
Alprazolam	Alprazolam	118	26
Allopurinol	Allopurinol	107	25
Tramadol Hcl	Tramadol Hcl	97	28
Lorazepam	Lorazepam	95	16
Metformin Hcl Er	Metformin Hcl	95	26
Prednisone	Prednisone	95	53
Ozempic	Semaglutide	91	17
Meloxicam	Meloxicam	78	23
Carvedilol	Carvedilol	77	18
Ezetimibe	Ezetimibe	73	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	15
Glipizide Er	Glipizide	71	16
Fluoxetine Hcl	Fluoxetine Hcl	70	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	12
Celecoxib	Celecoxib	69	14
Ropinirole Hcl	Ropinirole Hcl	69	15
Fluticasone Propionate	Fluticasone Propionate	68	24
Hydralazine Hcl	Hydralazine Hcl	68	18
Tizanidine Hcl	Tizanidine Hcl	67	14
Clopidogrel	Clopidogrel Bisulfate	64	18
Duloxetine Hcl	Duloxetine Hcl	64	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	18
Amitriptyline Hcl	Amitriptyline Hcl	61	suppressed
Glimepiride	Glimepiride	60	13
Nystatin	Nystatin	59	22
Clonazepam	Clonazepam	58	suppressed
Pregabalin	Pregabalin	57	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	suppressed
Atenolol	Atenolol	54	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	17
Finasteride	Finasteride	48	suppressed
Mirtazapine	Mirtazapine	46	11
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Memantine Hcl	Memantine Hcl	42	suppressed
Linzess	Linaclotide	40	suppressed
Myrbetriq	Mirabegron	40	suppressed
Spironolactone	Spironolactone	40	11
Chlorthalidone	Chlorthalidone	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	30
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	11
Trulicity	Dulaglutide	36	suppressed
Meclizine Hcl	Meclizine Hcl	35	suppressed
Ondansetron Odt	Ondansetron	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Famotidine	Famotidine	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	13
Montelukast Sodium	Montelukast Sodium	32	14
Donepezil Hcl	Donepezil Hcl	31	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	15
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Glipizide	Glipizide	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Baclofen	Baclofen	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Ramipril	Ramipril	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Colchicine	Colchicine	21	suppressed
Topiramate	Topiramate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	20	suppressed
Primidone	Primidone	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Cephalexin	Cephalexin	18	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Sumatriptan	Sumatriptan	15	suppressed
Temazepam	Temazepam	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Digoxin	Digoxin	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Estradiol	Estradiol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error